CHEK2 and neoplasm: MK-8745-resistant clones of HCT116 Puma(-/-), HCT116 Bax(-/-), HCT116 p53(-/-), and HCT116 Chk2(-/-) cells showed slightly slow tumor development compared to each of the original control cells.